Risk Assessment Tools and the Identification of Individuals at High-Risk of HIV infection in the Delivery of Oral PrEP
This analysis can assist partners and implementers with understanding who is at high-risk of HIV acquisition, how best to reach them, and how to support high-levels of oral PrEP uptake and strong adherence. Click here to access a summary of the findings or for a page detailing all of the tools assessed.
HIV Pre-exposure Prophylaxis (PrEP) Knowledge among General Practitioners in 2020: A French survey
This article from Infectious Diseases Now analyses the knowledge of and position on PrEP amongst general practitioners in Hauts-de-France, France.
An Update on Expanding HIV Preexposure Prophylaxis
This article from the Journal of the American Academy of Physicians Assistants describes how to better employ PrEP in the United States in light of changes to the Centers for Disease Control guidelines on PrEP counselling, monitoring, and delivery, and approval of injectable cabotegravir for PrEP by the US Food and Drug Administration.
Same-day Initiation of Oral Pre-exposure Prophylaxis among Gay, Bisexual, and Other Cisgender Men who Have Sex with Men and Transgender Women in Brazil, Mexico, and Peru (ImPrEP): A prospective, single-arm, open-label, multicentre implementation study
This article from The Lancet HIV assesses the feasibility of same-day oral PrEP delivery amongst gay and bisexual men who have sex with men and transgender women in Brazil, Mexico, and Peru.
Cost-effectiveness Analysis of the Daily HIV Pre-exposure Prophylaxis in Men who Have Sex with Men in Barcelona
This article from PLOS One models the cost-effectiveness of daily oral PrEP use amongst gay and bisexual men who have sex with men in Barcelona, Spain.
Estimating the Impact of HIV PrEP Regimens Containing Long-acting Injectable Cabotegravir or Daily Oral Tenofovir Disoproxil Fumarate/Emtricitabine among Men who Have Sex with Men in the United States: A mathematical modelling study for HPTN 083
This article from The Lancet Regional Health- Americas describes the results of a modelling exercise which compares the potential population-level impact of oral PrEP (TDF/FTC) and Cabotegravir for PrEP among gay and bisexual men who have sex with men in Atlanta, Georgia, USA.
Nurse-facilitated PrEP Delivery for Adolescent Girls and Young Women Seeking Contraception at Retail Pharmacies in Kisumu, Kenya
This article from AIDS evaluates PrEP uptake, initiation, and continuation within a nurse-facilitated pharmacy-based delivery model for Kenyan adolescent girls and young women seeking contraception at retail pharmacies.
Efficacy of Daily Text Messaging to Support Adherence to HIV Pre-Exposure Prophylaxis (PrEP) among Stimulant-Using Men Who Have Sex with Men
This article from Substance Use & Misuse evaluates the efficacy of the individualized Texting for Adherence Building (iTAB) intervention for PrEP adherence among 119 gay and bisexual men who have sex with men who use stimulants in California, USA.
Primary Care Provider HIV PrEP Knowledge, Attitudes, and Prescribing Habits: A cross-sectional survey of late adopters in rural and suburban practice
This article from the Journal of Primary Care & Community Health describes the current knowledge, attitudes, and prescribing behaviors of HIV PrEP in primary care providers in Pennsylvania, USA with a focus on the perceived barriers and facilitators to PrEP prescribing.
Young Adult Perspectives on Sex, Dating, and PrEP Use During the Pandemic and Improving the Future of PrEP Care
This article from AIDS and Behavior examines the experiences of young adults with sex, dating, and PrEP use during California’s Covid-19 “shelter-in-place” orders and their perceptions on how to improve PrEP care in this age group.
Differentiated HIV Services for Transgender People in Four South African Districts: Population characteristics and HIV care cascade
This article from the Journal of the International AIDS Society describes a differentiated service delivery model across four South African sites and transgender individuals who access these services. It assesses whether hormone therapy is associated with continued use of PrEP and viral load suppression.